Radiation boost could extend lives in High-Risk prostate cancer
NCT ID NCT07477626
Summary
This study compares two approaches for men whose prostate cancer has spread to nearby lymph nodes after surgery. Researchers want to see if adding pelvic radiation to standard hormone therapy helps keep the cancer from returning longer than hormone therapy alone. About 374 participants will be randomly assigned to receive either the combination treatment or just hormone therapy for two years, with researchers tracking cancer recurrence, survival, and side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER (POST PROSTATECTOMY) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Affiliated Hospital of Guangdong Medical University
Zhanjiang, Guangdong, China
-
Beijing Hospital
Beijing, China
-
Cancer Hospital, Chinese Academy of Medical Sciences
Beijing, China
-
Peking University First Hospital
Beijing, China
-
Peking University Third Hospital
Beijing, China
-
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, 510060, China
-
The First Affiliated Hospital of Naval Medical University
Shanghai, China
-
The First Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
-
West China Hospital, Sichuan University
Chengdu, Sichuan, China
Conditions
Explore the condition pages connected to this study.